In contrast, NKILA interacts with mir-582-3p regulated by m6A methyltransferase METTL3 and inhibits its expression, thereby accelerating cholangiocarcinoma progression through YAP1 [34]. Here, YAP1 is linked to cholangiocarcinoma.